CXCR4 and eating disorder: Because off-label treatment of patients with AN with metreleptin has been associated with a rapid and prominent amelioration of emotional, cognitive and behavioral symptoms of this eating disorder (92, 93), it is tempting to speculate that one of the underlying mechanisms may relate to a metreleptin induced down-regulation of CXCR4.